21848202

Source:http://linkedlifedata.com/resource/pubmed/id/21848202

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0042313, umls-concept:C0065023, umls-concept:C0239998, umls-concept:C0456387, umls-concept:C0871261, umls-concept:C1704243, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	7
pubmed:dateCreated	2011-8-18
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9303583
pubmed:citationSubset	H
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aminoglycosides, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Vancomycin, http://linkedlifedata.com/resource/pubmed/chemical/lipiarmycin
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1062-3388
pubmed:author	pubmed-author:MorrowThomasT
pubmed:issnType	Print
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	49-50
pubmed:meshHeading	pubmed-meshheading:21848202-Aminoglycosides, pubmed-meshheading:21848202-Anti-Bacterial Agents, pubmed-meshheading:21848202-Clostridium Infections, pubmed-meshheading:21848202-Clostridium difficile, pubmed-meshheading:21848202-Comparative Effectiveness Research, pubmed-meshheading:21848202-Cost-Benefit Analysis, pubmed-meshheading:21848202-Humans, pubmed-meshheading:21848202-Recurrence, pubmed-meshheading:21848202-Vancomycin
pubmed:year	2011
pubmed:articleTitle	Fewer recurrent infections of C. difficile seen with fidaxomicin. This new class of antibiotic--the macrocycles--has a greater sustained response against re-infection than vancomycin.
pubmed:affiliation	Genentech, USA. TMorrow@ManagedCareMag.com
pubmed:publicationType	Journal Article